Feasibility Study of BMAC Enhanced CABG

Inclusion Criteria: * Age\> 18 years and ability to understand the planned treatment. * Patients with ischemic congestive heart failure requiring by pass surgery * Congestive heart failure with ejection fraction ≤ 40%. * Serum bilirubin, SGOT and SGPT ≤2.5 time the upper level of normal. * Serum creatinine \< 3.0 or no dialysis. * NYHA performance status ≥ 3. * Negative pregnancy test (in women with childbearing potential). * Subject has read and signed the IRB approved Informed Consent form * Hematocrit ≥ 28.0%, White Blood Cell count ≤ 14,000, Platelet count ≥ 50,000, Creatinine ≤ 3.0 mg / Dl, and/or no dialysis, INR ≤ 1.6 unless on Coumadin, or PTT \<1.5 x control (to avoid bleeding complications) Patients on Coumadin will be corrected prior to the procedure and must have an INR\<1.6 at the time of randomization/surgery Exclusion Criteria: * Female who is pregnant or nursing, or of child bearing potential and is not using a reliable birth control method, or who intend to become pregnant during the tenure of this study. * History of Prior Radiation Exposure for oncological treatment. * History of Bone Marrow Disorder (especially NHL, MDS) that prohibit transplantation. * History of abnormal Bleeding or Clotting. * History of Liver Cirrhosis. * Acute Myocardial Infarction \< 4 weeks from treatment date. * Known active malignancy or results outside of normal limits from the following tests: PAP, Chest X-ray, PSA, Mammogram, Hemoccult unless follow-up studies reveal patient to be cancer free. * Active clinical infection being treated by antibiotics within one week of enrollment * Terminal renal failure with existing dependence on dialysis * Inability or unwillingness to comply with the treatment protocol, follow-up, research tests, or give consent. * Unable to have 250cc bone marrow harvested. * Medical risk that precludes anesthesia or ASA Class 5 * History of ventricular arrhythmia if AICD is not present. * History of ventricular aneurysm. * Concurrent surgery such as CABG with valve surgery. * Minimally Invasive bypass surgery * Life expectancy \<6 months due to concomitant illnesses * Treatment with immunosuppressant drugs (including Prednisone \> 5 mg per day) * Patients undergoing urgent by pass surgical procedure * Patients with HGB A1C \> 8.5%